Table 3.
Glycemic variables across the study period categorized by group
| Variable | Cur (n = 10) | Pla (n = 10) | Pla+Tra (n = 10) | Cur+Tra (n = 10) | P* |
|---|---|---|---|---|---|
| Insulin (μU/mL) | 0.353 | ||||
| Before | 8.07±3.79 | 7.25±3.12 | 7.85±2.85 | 9.17±3.32 | |
| After | 7.83±2.99 | 8.38±3.64 | 7.92±2.15 | 7.27±2.29 | |
| P† | 0.844 | 0.181 | 0.942 | 0.039 | |
| PC | 10.76±60.05 | 19.10±33.73 | 8.09±38.02 | –17.43±21.73 | |
| FPG (mg/dL) | 0.388 | ||||
| Before | 96.50±12.05 | 93.40±9.96 | 92.20±6.32 | 93.30±5.83 | |
| After | 88.20±4.68 | 93.40±17.57 | 88.80±3.82 | 90.5±7.50 | |
| P† | 0.041 | 1 | 0.108 | 0.389 | |
| PC | –7.57±10.37 | –0.48±11.19 | –3.38±6.33 | –2.59±11.12 | |
| HOMA-IR | 0.289 | ||||
| Before | 2.00±1.22 | 1.72±0.91 | 1.78±0.64 | 2.12±0.82 | |
| After | 1.69±0.65 | 1.98±1.14 | 1.73±0.44 | 1.61±0.50 | |
| P† | 0.414 | 0.245 | 0.800 | 0.053 | |
| PC | 4.84±64.27 | 18.00±33.58 | 4.19±36.03 | –18.72±25.34 | |
| QUICKI | 0.452 | ||||
| Before | 0.35±0.03 | 0.36±0.02 | 0.35±0.17 | 0.34±0.17 | |
| After | 0.36±0.02 | 0.35±0.02 | 0.35±0.01 | 0.36±0.02 | |
| P† | 0.673 | 0.258 | 0.988 | 0.044 | |
| PC | 1.58±8.10 | –1.72±5.03 | 0.12±4.58 | 4.10±5.52 | |
Values are presented as mean± standard deviation.
*
Data analysis was done by analysis of covariance and least significant difference post-hoc tests after adjustment for baseline values; †Statistical analysis was done by paired sample t-test.
Cur, curcumin supplement; Pla, placebo; Pla+Tra, placebo+aerobic training; Cur+Tra, curcumin supplement+aerobic training; PC, percent change; FPG, fasting plasma glucose; HOMA-IR, homeostatic model assessment for insulin resistance; QUICKI, quantitative insulin sensitivity check index.